The Blog
-
Nov 12, 2024Advancing Cancer Therapy with Catalytic Topoisomerase II Inhibitors: A Safer Pathway Forward
READ MORE -
Oct 30, 2024The Role of Cyclin-Dependent Kinases (CDKs) in Cancer: Biomarkers, Therapeutic Targets, and Future Directions
READ MORE -
Aug 12, 2024Exploring the Versatility of Heparin: From Anticoagulant to Multifaceted Therapeutic Agent
READ MORE -
Jul 08, 2024Nintedanib: A Multifaceted Tyrosine Kinase Inhibitor
READ MORE -
Jun 07, 2024Exploring the Role of Toll-like Receptor (TLR) Agonists in Cancer Therapy
READ MORE -
Apr 06, 2023Dopamine Receptor and Cancer
READ MORE